Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Venous Thromboembolism × Tinzaparin × Clear all

Phase

Status

Terminated 4 Completed 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Rivaroxaban 2 Tinzaparin 1 Surveys and Questionnaires 1 Long-Term Synaptic Depression 1 Heparin, Low-Molecular-Weight 1 Enoxaparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

The University of Hong Kong

Phase 3 Unknown

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡